RGLS Regulus Therapeutics Inc

Regulus Therapeutics Inc is a biotechnology company that focuses on the development of microRNA therapies. MicroRNA is a noncoding ribonucleic acid that regulates most genes in the genome.

As of 05/10/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  10/04/2012
Outstanding shares:  74,923,660
Average volume:  1,591,758
Market cap:   $68,562,641
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    75915K200
ISIN:        US75915K2006
Sedol:      BD0BPN1
Valuation   (See tab for details)
PE ratio:   -7.37
PB ratio:   4.37
PS ratio:   6.85
Return on equity:   -60.44%
Net income %:   -157.21%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy